Accordingly, in a different subtype of bladder cancer, muscle-invasive bladder cancer, recurrent mutations in RXRα lead to an imbalance of the PPARγ/RXRα heterodimer, and focal amplification of PPARγ. This evidence concerns the gene RXRA and urinary bladder carcinoma.